1. Home
  2. ACRV vs MHH Comparison

ACRV vs MHH Comparison

Compare ACRV & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.69

Market Cap

74.0M

Sector

Health Care

ML Signal

HOLD

Logo Mastech Digital Inc

MHH

Mastech Digital Inc

HOLD

Current Price

$6.45

Market Cap

76.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRV
MHH
Founded
2018
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
74.0M
76.3M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
ACRV
MHH
Price
$1.69
$6.45
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $11.50
N/A
AVG Volume (30 Days)
★ 267.1K
6.0K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 15.13
N/A
EPS
N/A
★ 0.01
Revenue
N/A
★ $191,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.86
P/E Ratio
★ N/A
$635.00
Revenue Growth
★ N/A
N/A
52 Week Low
$1.27
$5.50
52 Week High
$3.56
$8.37

Technical Indicators

Market Signals
Indicator
ACRV
MHH
Relative Strength Index (RSI) 38.70 26.22
Support Level $1.61 $5.61
Resistance Level $2.21 $6.73
Average True Range (ATR) 0.11 0.36
MACD -0.03 -0.06
Stochastic Oscillator 15.47 0.00

Price Performance

Historical Comparison
ACRV
MHH

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1; ACR-2316 a selective, dual WEE1/PKMYT1 inhibitor; and ACR-6840, a development candidate targeting CDK11. It has one reportable segment focused on the research and development of precision oncology therapies.

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. The IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: